Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2012 May 26;138(15):656-9.
doi: 10.1016/j.medcli.2011.10.027. Epub 2012 Mar 6.

[Anemia in heart failure: its usefulness as prognosis or comorbidity marker: GESAIC-2 study]

[Article in Spanish]
Affiliations
Multicenter Study

[Anemia in heart failure: its usefulness as prognosis or comorbidity marker: GESAIC-2 study]

[Article in Spanish]
Jorge Grau-Amorós et al. Med Clin (Barc). .

Abstract

Background and objective: To assess the prognosis and etiology of anemia in heart failure (HF).

Patients and methods: Prospective multicenter cohort of HF after one year of hospitalization.

Results: A total of 57 (27%) of the 211 patients died and 115 (67.8%) were readmitted. Mortality was higher in the group with anemia (31.8%) without statistical significance (P=.09), except for refractory HF mortality (P=.013). Predictors of HF mortality included Barthel index (hazard ratio [HR] 0.97, CI 95% 0.96 to 0.98) and serum creatinine at discharge (HR 2.28, 95% CI 1.51 to 3.45). For reentry, the Charlson index (OR 1.16, CI 95% 0.98 to 1.38), treatment with calcium channel blockers (OR 0.29, 95% CI 0.1 to 0.84) and not being treated with digoxin (OR 2.33, CI 95% 1.09 to 4.97), the latter with the greatest influence on readmission for HF (OR 3.07, CI 95% 1.39 to 6.79), along with not being a HF debut (OR 2.8, CI 95% 1.45 to 5.39).

Conclusions: Anemia is an increased risk of mortality due to refractory HF, but not for readmission within the first year after an acute event.

PubMed Disclaimer